Identity Mrs.
PURNITA/42 YO/1220648/OGAN KOMERING/P4A0/FIF-IKY/ RS
Chief complaint Vaginal bleeding since 10 hours ago
Recent illness Chief complaint : vaginal bleeding since 10 hours ago
history Patient came with complaint there was vaginal bleeding since 10 hours ago, 2x
changing pad. History postcoital bleeding (+), body weakness (+), weight loss and
loss of apetite (+). Defecation and micturition was normal. Patient had complete
chemotherapy (Cysplatin), external (32x) and internal (3x) radiation at 15 September
2022.
Past Illness History Chemoterapy cysplatin
External radiation 32x
Internal radiation 3x
Marital status Married 20 years
Reproduction Menopause since 9 month ago
status
Obstetric history P4A0
Physical BP: 100/70 mmHg Pulse: 92 bpm T: 36.6oC, RR : 18x/m
Examination BW 53 kg BH 155 cm
Head: normocephalic, pallor conjunctiva (+/+), icteric sclera (-/-)
Neck: JVP (5-2) cmH2O, lymph nodes enlargement (-), thyroid glands
enlargement (-)
Thorax:
Cor: Normal I-II heart sound, murmur (-), gallop (-)
Lungs: normal vesicular sound (+/+), rhonchi (-/-), wheezing (-/-)
Extremities: pretibial edema (-/-)
Gynecology External examination :
examination Flat, supple, tenderness (-), mass (-), uterine fundal height unpalpable,
free fluid sign (-)
Speculum examination :
Exophytic mass at portio, bumpy surface, fragile, easy to bleed,
invade 1/3 proximal vagina
Vaginal toucher :
Exophytic mass at portio, bumpy surface, fragile, easy to bleed,
invade 1/3 proximal vagina, both AP was tensed
Rectal toucher :
Empty ampulla recti, intraluminal mass (-), CFS 0%-25%
US examination - Anteflexed uterus, size 7.70 x 4.31 cm, cavum uterine opened, myometrium
homogen.
- There was hyperechoic mass with neovascularization (+) at cervix size 2.42 x
2.89 cm invasive 1/3 proximal vagina ~ cervical malignancy mass was
suspected
- Right renal within normal limit
- Left hydronephrosis – hydroureter
- There was enlargement of parailiac and paraaortic lymph node
- Both ovary within normal limit
- Liver and spleen in normal limit
C/
Cervical malignancy mass
Left hydronephrosis – hydroureter
Enlargement of parailiac and paraaortic lymph node
Laboratory Hb 6.2 g/dL; RBC 2.22/mm3; WBC 12.050/mm3; Ht 17%; PLT 249.000/µL; MCV
examination
(6.11.22) 75.2 fL; MCH 28 pg; MCHC 37 g/dL; RDW-CV 14.40%; D/C 0/0/93/4/3
PT 16.0 second; INR 1.24; APTT 31.1 second; Ca 8.2; AST/ALT 12/8 U/L; Albumin
3.4 g/dL; BSS 113 mg/dL; U/C 28/0.47 mg/dL; Na 127 mg/dL; K 4.2 mg/dL
HBsAg non reactive; TPHA non reactive; VDRL non reactive; Anti HIV non
reactive
Anti SARS-CoV-2 : Ig M and IgG non reactive
Diagnosis • Cervical cancer stage IIIB complete therapy (C53.9)
• Severe anemia normocytic hipochrome (D64.9)
Management
• Observation vital sign and bleeding (V72.62)
• General condition improvement (V65.9)
• PRC transfusion (99.04)
• US confirmation (88.74)